PI3K/Akt in IPF: untangling fibrosis and charting therapies.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1549277
- By:
- Publication type:
- Article
Works matching DE "IDIOPATHIC pulmonary fibrosis"
Results: 7
1
2
PI3K/Akt in IPF: untangling fibrosis and charting therapies.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1549277
- By:
- Publication type:
- Article
3
Studying the efficacy of JBOL volatile components in idiopathic pulmonary fibrosis (IPF) using GC-MS and network pharmacology.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-97374-9
- By:
- Publication type:
- Article
4
Identifying TNFSF4<sup>low</sup>-MSCs superiorly treating idiopathic pulmonary fibrosis through Tregs differentiation modulation.
- Published in:
- Stem Cell Research & Therapy, 2025, v. 16, n. 1, p. 1, doi. 10.1186/s13287-025-04313-6
- By:
- Publication type:
- Article
5
Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-59093-7
- By:
- Publication type:
- Article
6
Pulmonary Fibrosis in a Patient With a Prolactinoma on Dopamine Agonists: Coincidence or Consequence.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
7
Polypharmacy and potentially inappropriate medication (PIM) use among older veterans with idiopathic pulmonary fibrosis (IPF) – a retrospective cohort study.
- Published in:
- BMC Pulmonary Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12890-025-03611-2
- By:
- Publication type:
- Article